Focus Partners Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.6M Sell
391,155
-41,967
-10% -$3.39M 0.03% 418
2026
Q1
$37.5M Sell
433,122
-30,338
-7% -$2.91M 0.04% 351
2025
Q4
$44.5M Buy
463,460
+239,265
+107% +$23.2M 0.05% 311
2025
Q3
$21.4M Buy
224,195
+20,448
+10% +$1.88M 0.03% 392
2025
Q2
$17.8M Sell
203,747
-7,789
-4% -$661K 0.04% 384
2025
Q1
$19M Buy
211,536
+6,928
+3% +$620K 0.05% 334
2024
Q4
$16.3M Buy
204,608
+105,192
+106% +$9.11M 0.04% 358
2024
Q3
$27.7M Sell
99,416
-90,931
-48% -$7.65M 0.09% 228
2024
Q2
$15M Buy
190,347
+14,620
+8% +$1.2M 0.05% 291
2024
Q1
$15.3M Buy
175,727
+119,231
+211% +$10.2M 0.12% 169
2023
Q4
$4.65M Buy
+56,496
New +$4.31M 0.06% 240

Other funds holding MDT

Focus Partners Wealth's MDT Position: Q2 2026 in Review

Focus Partners Wealth reduced its Medtronic (MDT) stake by 9.7% in Q2 2026, selling an estimated $3.39M and leaving 391,155 shares worth $30.6M. The position accounts for 0.03% of the portfolio, ranked #418.

Focus Partners Wealth first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $44.5M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Focus Partners Wealth held 391,155 shares of Medtronic worth $30.6M as of Q2 2026.
  • Focus Partners Wealth sold 41,967 Medtronic shares in Q2 2026, an estimated $3.39M.
  • Medtronic made up 0.03% of Focus Partners Wealth's portfolio in Q2 2026, its #418 holding.
  • Focus Partners Wealth first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Medtronic position peaked at $44.5M in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.